John Militello files SEC Form 4 disclosures for ROCKET PHARMACEUTICALS, INC.. They have made 30 open-market trades across 1 company since 2023, most recently 2026-05-19.
CIK 0001662170
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 30 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RCKT | 89,780 | $195K |
Shares reported on the most recent Form 4, priced at the 2026-05-21 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RCKT | SELL | 2026-05-19 | 2026-05-21 | $3.01 | $1K | -5.0% | +12.4% | +18.9% |
| RCKT | SELL | 2026-05-13 | 2026-05-14 | $3.61 | $3K | -11.7% | -15.6% | +0.4% |
| RCKT | SELL | 2026-02-18 | 2026-02-20 | $3.34 | $4K | +26.8% | +14.2% | -18.4% |
| RCKT | SELL | 2026-02-13 | 2026-02-18 | $3.31 | $12K | +44.9% | +20.8% | -15.2% |
| RCKT | SELL | 2025-11-18 | 2025-11-20 | $2.98 | $3K | +18.0% | +24.7% | +21.9% |
| RCKT | SELL | 2025-10-14 | 2025-10-16 | $3.96 | $193K | +1.3% | -22.4% | +1.0% |
| RCKT | SELL | 2025-08-18 | 2025-08-20 | $3.05 | $3K | -13.8% | -18.4% | -21.8% |
| RCKT | SELL | 2025-08-14 | 2025-08-18 | $3.02 | $21K | +10.6% | +0.0% | +0.3% |
| RCKT | SELL | 2025-05-20 | 2025-05-22 | $6.45 | $2K | -54.0% | -58.6% | -40.9% |
| RCKT | SELL | 2025-05-16 | 2025-05-20 | $6.53 | $4K | -58.5% | -59.6% | -54.6% |
| RCKT | SELL | 2025-04-22 | 2025-04-24 | $7.16 | $5K | -13.6% | -68.1% | -54.0% |
| RCKT | SELL | 2025-02-21 | 2025-02-25 | $10.58 | $29K | -7.8% | -17.1% | -75.5% |
| RCKT | SELL | 2025-01-23 | 2025-01-27 | $10.38 | $9K | -0.4% | -10.9% | -33.0% |
| RCKT | SELL | 2024-11-21 | 2024-11-25 | $13.05 | $16K | -0.6% | -14.0% | -28.1% |
| RCKT | SELL | 2024-10-31 | 2024-11-04 | $16.63 | $15K | -10.6% | -18.1% | -36.3% |
| RCKT | SELL | 2024-08-16 | 2024-08-20 | $18.50 | $20K | -3.0% | +9.9% | -29.7% |
| RCKT | SELL | 2024-07-22 | 2024-07-24 | $23.02 | $19K | -20.2% | -25.7% | -29.2% |
| RCKT | SELL | 2024-05-16 | 2024-05-20 | $23.35 | $25K | -5.9% | -7.9% | -15.2% |
| RCKT | SELL | 2024-04-22 | 2024-04-24 | $22.87 | $19K | +0.3% | -7.4% | +7.5% |
| RCKT | SELL | 2024-03-21 | 2024-03-25 | $28.10 | $70K | -7.5% | -12.6% | -11.0% |
| RCKT | SELL | 2024-02-29 | 2024-03-04 | $29.85 | $299K | -3.2% | -9.7% | -22.2% |
| RCKT | SELL | 2024-02-16 | 2024-02-21 | $29.84 | $193K | +1.0% | -4.3% | -21.5% |
| RCKT | SELL | 2024-01-22 | 2024-01-23 | $27.20 | $17K | +0.1% | +1.7% | -16.3% |
| RCKT | SELL | 2023-10-20 | 2023-10-25 | $17.06 | $10K | +10.3% | +23.1% | +56.1% |
| RCKT | SELL | 2023-08-17 | 2023-08-21 | $15.47 | $4K | -1.4% | +38.3% | +38.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.